Related Experiment Video
Updated: Feb 13, 2026

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
Published on: March 18, 2014
ING5 is a Potential Target for Osteosarcoma Therapy
Xing Zhang1, Zhong-Hua Xu1, Hua Xie1
11 Department of Orthopedics, Jintan Hospital Affiliated to Jiangsu University, Jintan, Jiangsu, People's Republic of China.
Abstract:
Osteosarcoma is one of the most common primary malignant bone tumors. The inhibitor of growth family of protein 5 has been identified as a tumor suppressor in many cancers. In this study, we confirmed the downregulation of the both inhibitor of growth family of protein 5 and messenger RNA levels in cancer tissues using Western blot and real-time polymerase chain reaction. In order to find the antitumor roles of inhibitor of growth family of protein 5, osteosarcoma cells, HOS, and MG63 were transfected with the plasmid pCDNA-3.1-inhibitor of growth family of protein 5. Overexpression of Inhibitor of growth family of protein 5 could induce apoptosis and inhibit cell proliferation in osteosarcoma cells. Furthermore, Western blot analysis showed that p-Smad2, p-Smad3, and Smad4 were increased in inhibitor of growth family of protein 5-expressing osteosarcoma cells. Our results indicated that overexpression of inhibitor of growth family of protein 5 in osteosarcoma cells induces apoptosis by activating the Smad pathway, thus proposing a promising role for inhibitor of growth family of protein 5 in treatment of patients with osteosarcoma.
Insights
Inhibitor of growth family of protein 5 (IGF5) is downregulated in osteosarcoma. Overexpressing IGF5 induces apoptosis and inhibits proliferation by activating the Smad pathway, suggesting its potential as an osteosarcoma treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Osteosarcoma is a common primary malignant bone tumor.
- The inhibitor of growth family of protein 5 (IGF5) acts as a tumor suppressor in various cancers.
- IGF5 downregulation is observed in osteosarcoma tissues.
Purpose of the Study:
- To investigate the antitumor roles of IGF5 in osteosarcoma.
- To determine the mechanism by which IGF5 affects osteosarcoma cell behavior.
- To explore the potential of IGF5 as a therapeutic target for osteosarcoma.
Main Methods:
- Western blot and real-time polymerase chain reaction to confirm IGF5 downregulation.
- Transfection of osteosarcoma cell lines (HOS, MG63) with IGF5 plasmid.
- Analysis of apoptosis, cell proliferation, and Smad pathway activation (p-Smad2, p-Smad3, Smad4).
Main Results:
- IGF5 and its mRNA levels were confirmed to be downregulated in osteosarcoma tissues.
- Overexpression of IGF5 in osteosarcoma cells induced apoptosis and inhibited cell proliferation.
- Activation of the Smad pathway (increased p-Smad2, p-Smad3, and Smad4) was observed in IGF5-expressing cells.
Conclusions:
- Overexpression of IGF5 induces apoptosis in osteosarcoma cells via Smad pathway activation.
- IGF5 demonstrates significant antitumor effects in osteosarcoma.
- IGF5 presents a promising therapeutic target for osteosarcoma treatment.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Gene Therapy
Potential Energy
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...
Standard Electrode Potentials
Group Therapy
Cell Potential and Free Energy
Thermodynamics is the branch of physics dealing with the relationship between heat and other forms of energy. In an electrochemical cell, chemical energy is converted into electrical energy.
Thus, a link can be predicted between cell potential, free energy change, and the equilibrium constant for the reaction. Cell potential can also be measured as the oxidant or the reducing strength, and similar acid-base strength measures are reflected in equilibrium...

